These effects, along with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the principle of concentrating on ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Problems. (2) The physician has received https://joshw665ybu2.wikififfi.com/user